Skip to main content
Log in

Left-sided congenital heart lesions in mosaic Turner syndrome

  • Original Article
  • Published:
Molecular Genetics and Genomics Aims and scope Submit manuscript

Abstract

In the era of the diseasomes and interactome networks, linking genetics with phenotypic traits in Turner syndrome should be studied thoroughly. As a part of this stratagem, mosaicism of both X and Y chromosome which is a common finding in TS and an evaluation of congenital heart diseases in the different situations of mosaic TS types, can be helpful in the identification of disturbed sex chromosomes, genes and signaling pathway actors. Here we report the case of a mosaic TS associated to four left-sided CHD, including BAV, COA, aortic aneurysms and dissections at an early age. The mosaicism included two cell lines, well-defined at the cytogenetic and molecular levels: a cell line which is monosomic for Xp and Xq genes (45,X) and another which is trisomic for pseudoautosomal genes that are present on the X and Y chromosomes and escape X inactivation: 45,X[8]/46,X,idic(Y)(pter→q11.2::q11.2→pter)[42]. This case generates two hypotheses about the contribution of genes linked to the sex chromosomes and the signaling pathways involving these genes, in left-sided heart diseases. The first hypothesis suggests the interaction between X chromosome and autosomal genes or loci of aortic development, possibly dose-dependent, and which could be in the framework of TGF-β-SMAD signaling pathways. The second implies that left-sided congenital heart lesions involve sex chromosomes loci. The reduced dosage of X chromosome gene(s), escaping X inactivation during development, contributes to this type of CHD. Regarding our case, these X chromosome genes may have homologues at the Y chromosome, but the process of inactivation of the centromeres of the isodicentric Y spreads to the concerned Y chromosome genes. Therefore, this case emerges as an invitation to consider the mosaics of Turner syndrome and to study their phenotypes in correlation with their genotypes to discover the underlying developmental and genetic mechanisms, especially the ones related to sex chromosomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AAAD:

Acute type A aortic dissection

ACTA2:

Actin, alpha-2, smooth muscle, aorta [MIM:102620] cytogenetic location:10q23.31

AGTR1:

Angiotensin II receptor type 1 [MIM:106165] cytogenetic location:3q24

AGTR2:

Angiotensin II receptor type 2 [MIM:300034] cytogenetic location:Xq23

AngII:

Angiotensin II

AS:

Aortic stenosis

AZF:

Azoospermia factor

BAV:

Bicuspid aortic valve

bp:

Base pair

CEP:

DNA probe specific for the alpha satellite (centromeric) region

cGMP:

Cyclic guanosine monophosphate

CHD:

Congenital heart disease

CNV:

Copy number variant

COA:

Aortic coarctation

der(Y):

Derivative of Y chromosome

DNA:

Deoxyribonucleic acid

EDTA:

Ethylenediaminetetraacetic acid

FISH:

Fluorescence in situ hybridization

idic:

Isodicentric

KCl:

Potassium chloride

LSI:

Locus-specific identifier probe

MAT2A:

Methionine adenosyltransferase II, alpha [MIM:601468] cytogenetic location:2p11.2

MFAP5:

Microfibrillar-associated protein 5 [MIM:601103] cytogenetic location:12p13.31

MRI:

Magnetic resonance imaging

MYH11:

Myosin, heavy chain 11, smooth muscle [MIM:160745] cytogenetic location:16p13.11

MYLK:

Myosin light chain kinase [MIM:600922] cytogenetic location:3q21.1

NANOGP1:

NANOG homeobox pseudogene 1 (NCBI Gene ID:404635) cytogenetic location:12p13.31

PCR:

Polymerase chain reaction

PRKG1:

Protein kinase, cGMP-dependent regulatory, type I [MIM:176894] cytogenetic location:10q11.2-q21.1

RHG banding:

Reverse banding using heat and giemsa

SHOX:

Short stature homeobox gene [MIM:312865] cytogenetic location:Xp22.33

SLC2A14:

Solute carrier family 2 (facilitated glucose transporter), member 14 pseudogene [MIM:611039] cytogenetic location:12p13.31

SLC2A3:

Solute carrier family 2 (facilitated glucose transporter), member 3 pseudogene [MIM:138170] cytogenetic location:12p13.31

SMAD 3:

Mothers against decapentaplegic, DroSophila, homolog 3 [MIM:603109] cytogenetic location:15q22.33

SMAD:

Contraction of Sma and Mad, homologs of both the Drosophila protein, mothers against decapentaplegic (MAD) and the Caenorhabditis elegans protein SMA from gene sma for small body size

SRY:

Sex-determining Region Y [MIM:480000] cytogenetic location:Yp11.2

STS:

Sequence-tagged site

TGFBR1:

Transforming growth factor-beta receptor, type I [MIM:190181] cytogenetic location:9q22.33

TGFBR2:

Transforming growth factor-beta receptor, type II [MIM:190182] cytogenetic location:3p24.1

TGF-β:

Transforming growth factor-beta

vs:

Versus

TS:

Turner syndrome

ZFX/Y:

Sequences homologous to the human X- and Y-borne zinc finger protein genes

ZFX:

Zinc finger protein, X-linked [MIM:314980] cytogenetic location:Xp22.11

ZFY:

Zinc finger protein, Y-linked [MIM:490000] cytogenetic location:Yp11.2

References

  • Abdelmoula NB, Amouri A (2005a) Dicentric Y chromosomes. First part: cytogenetic and molecular aspects. Ann Biol Clin (Paris) 63(3):263–278

    CAS  Google Scholar 

  • Abdelmoula NB, Amouri A (2005b) Dicentric Y chromosome. Ann Biol Clin (Paris) 63(4):363–375

    CAS  Google Scholar 

  • Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC et al (2014) MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 95(6):736–743

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Berletch JB, Yang F, Xu J, Carrel L, Disteche CM (2011) Genes that escape from X inactivation. Hum Genet 130(2):237–245

    Article  PubMed  PubMed Central  Google Scholar 

  • Bispo AV, Burégio-Frota P, Oliveira dos Santos L, Leal GF, Duarte AR, Araújo J et al (2014) Y chromosome in Turner syndrome: detection of hidden mosaicism and the report of a rare X;Y translocation case. Reprod Fertil Dev 26(8):1176–1182

    Article  CAS  PubMed  Google Scholar 

  • Bondy C (2014) Recent developments in diagnosis and care for girls in Turner Syndrome. Adv Endocrinol 2014:231089. https://doi.org/10.1155/2014/231089

    Article  Google Scholar 

  • Bondy C, Bakalov VK, Cheng C, Olivieri L, Rosing DR, Arai AE (2013) Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. J Med Genet 50(10):662–665

    Article  PubMed  PubMed Central  Google Scholar 

  • Castro AV, Okoshi K, Ribeiro SM, Barbosa MF, Mattos PF, Pagliare L et al (2002) Cardiovascular assessment of patients with Ullrich–Turner’s Syndrome on Doppler echo cardiology and magnetic resonance imaging. Arq Bras Cardiol 78(1):51–58

    Article  PubMed  Google Scholar 

  • Cripe L, Andelfinger G, Martin LJ, Shooner K, Benson DW (2004) Bicuspid aortic valve is heritable. J Am Coll Cardiol 44:138–143

    Article  PubMed  Google Scholar 

  • Gøtzsche CO, Krag-Olsen B, Nielsen J, Sørensen KE, Kristensen BO (1994) Prevalence of cardiovascular malformations and association with karyotypes in Turner’s syndrome. Arch Dis Child 71(5):433–436

    Article  PubMed  PubMed Central  Google Scholar 

  • Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ et al (2013) Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am J Hum Genet 93(2):398–404

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B et al (2015) MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet 96(1):170–177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matura LA, Ho VB, Rosing DR, Bondy CA (2007) Aortic dilatation and dissection in Turner syndrome. Circulation 116(15):1663–1670

    Article  PubMed  Google Scholar 

  • Mortensen KH, Andersen NH, Gravholt CH (2012) Cardiovascular phenotype in Turner syndrome-integrating cardiology, genetics, and endocrinology. Endocr Rev 33(5):677–714

    Article  CAS  PubMed  Google Scholar 

  • Muenke M, Kruszka PS, Sable CA, Belmont JW (2012) Congenital heart disease: molecular genetics, principles of diagnosis and treatment. Karger Medical and Scientific Publishers, Basel

    Google Scholar 

  • Nataatmadja M, West J, Prabowo S, West M (2013) Angiotensin II receptor antagonism reduces transforming growth factor beta and SMAD signaling in thoracic aortic aneurysm. Ochsner J 13(1):42–48

    PubMed  PubMed Central  Google Scholar 

  • Oliveira RM, Verreschi IT, Lipay MV, Eça LP, Guedes AD, Bianco B (2009) Y chromosome in Turner syndrome: review of the literature. Sao Paulo Med J 127(6):373–378

    Article  PubMed  Google Scholar 

  • Pásaro Méndez E, Fernández García RM (2011) Turner syndrome and sex chromosomal mosaicism, advances in the study of genetic disorders, Dr. Kenji Ikehara (Ed). InTech

  • Prakash SK, Bondy CA, Maslen CL, Silberbach M, Lin AE, Perrone L et al (2016) Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry. Am J Med Genet A 170(12):3157–3164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ravel C, Siffroi JP (2009) Y chromosome structural abnormalities and Turner’s syndrome. Gynecol Obstet Fertil 37(6):511–518

    Article  CAS  PubMed  Google Scholar 

  • Stevens A, De Leonibus C, Hanson D, Dowsey AW, Whatmore A, Meyer S et al (2014) Network analysis: a new approach to study endocrine disorders. J Mol Endocrinol 52:R79–R93

    Article  CAS  PubMed  Google Scholar 

  • Ware SM, Jefferies JL (2012) New genetic insights into congenital heart disease. J Clin Exp Cardiol S8:003

    Google Scholar 

  • Zhong Q, Layman LC (2012) Genetic considerations in the patient with Turner syndrome—45,X with or without mosaicism. Fertil Steril 98(4):775–779

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank the parents of the girl described for allowing us to share her details.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nouha Bouayed Abdelmoula.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the reported case.

Additional information

Communicated by S. Hohmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bouayed Abdelmoula, N., Abdelmoula, B., Smaoui, W. et al. Left-sided congenital heart lesions in mosaic Turner syndrome. Mol Genet Genomics 293, 495–501 (2018). https://doi.org/10.1007/s00438-017-1398-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00438-017-1398-x

Keywords

Navigation